Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Nsclc Glh'

Nsclc Glh published presentations and documents on DocSlides.

Integration of Immunotherapy Across

Integration of Immunotherapy Across

  • karlyn-bohler
  • 51 Slides

the Spectrum of Lung Cancer. Karen Kelly, MD. Pro...

Slides last updated:

Slides last updated:

  • calandra-battersby
  • 7 Slides

October 2013. There are two main types of lung . ...

Detection of Mutations in EGFR in Circulating Lung-Cancer C

Detection of Mutations in EGFR in Circulating Lung-Cancer C

  • sherrill-nordquist
  • 12 Slides

Colin Reisterer and Nick Swenson. S. . Maheswaran...

Michael

Michael

  • luanne-stotts
  • 62 Slides

Brada. . Torino. . 6 March 2015. Perspectives...

Lung malignancy

Lung malignancy

  • tawny-fly
  • 17 Slides

Dr. Rachel Cary, FY1 Warwick Hospital. Learning ...

Targeting KRAS and down streaming

Targeting KRAS and down streaming

  • alexa-scheidler
  • 51 Slides

pathways. Federico Cappuzzo. Istituto Toscano Tum...

Terapia

Terapia

  • min-jolicoeur
  • 40 Slides

targeted. : . limiti e successi nelle metastasi ...

MEK Inhibitors and their potential role in relapsed NSCLC

MEK Inhibitors and their potential role in relapsed NSCLC

  • debby-jeon
  • 30 Slides

Ranee Mehra, MD. Fox Chase Cancer Center. Philade...

David R.

David R.

  • alida-meadow
  • 47 Slides

Gandara. , MD. University of California, Davis . ...

Thierry

Thierry

  • cheryl-pisano
  • 40 Slides

Le Chevalier, . MD. The Role of Translational Res...

Second line

Second line

  • alida-meadow
  • 66 Slides

treatments. in WT . pts. : . which. . opportuni...

Slides last updated:

Slides last updated:

  • stefany-barnette
  • 25 Slides

October 2013 . Ferlay . J, Shin HR, Bray F, Forma...

Using Non-targeted Therapies in Targeted Lung Cancer Popula

Using Non-targeted Therapies in Targeted Lung Cancer Popula

  • ellena-manuel
  • 48 Slides

Nathan Pennell, M.D., Ph.D.. September 6, 2014. O...

Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)

Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)

  • stefany-barnette
  • 30 Slides

Renato G. Martins, MD, MPH. Medical Director, Tho...

Integration of Immunotherapy Across

Integration of Immunotherapy Across

  • pamella-moone
  • 51 Slides

the Spectrum of Lung Cancer. Karen Kelly, MD. Pro...

Italian cohort of

Italian cohort of

  • test
  • 3 Slides

nivolumab. Expanded Access . Programme. (EAP): ...

NSCLC with high PD-L1 expression on tumor cells or tumor-in

NSCLC with high PD-L1 expression on tumor cells or tumor-in

  • test
  • 5 Slides

Intervista a Federico . Cappuzzo. Background:. P...

Minesh Mehta, Northwestern University

Minesh Mehta, Northwestern University

  • mitsue-stanley
  • 40 Slides

Chicago, IL. Radiation for Prevention and Treatme...

Optimal treatment for elderly patients with NSCLC

Optimal treatment for elderly patients with NSCLC

  • cheryl-pisano
  • 43 Slides

Giorgio V. Scagliotti. University. of . Torino,....

L’algoritmo terapeutico

L’algoritmo terapeutico

  • calandra-battersby
  • 26 Slides

attraverso . i . c. asi clinici. Giuseppe . Valma...

Estimated costs of managing treatment-related adverse

Estimated costs of managing treatment-related adverse

  • lindy-dunigan
  • 8 Slides

eventsof. . nivolumab. and . docetaxel. in the...

James Yang,

James Yang,

  • pasty-toler
  • 93 Slides

MD. The Evolving Treatment Landscape in NSCLC: Co...

Comparision

Comparision

  • jane-oiler
  • 33 Slides

of the expression of . 17-beta-hydroxysteroid . ...

Antiangiogenic Agents in Advanced NSCLC

Antiangiogenic Agents in Advanced NSCLC

  • ellena-manuel
  • 0 Slides

Jared Weiss, MD . Assistant . Professor of Medici...

EGFR-Mutated Advanced NSCLC

EGFR-Mutated Advanced NSCLC

  • sherrill-nordquist
  • 0 Slides

The Coming Paradigm Shift. Faculty. Suresh S. Ram...

EGFR-Mutated NSCLC and CNS Involvement: the Conundrum

EGFR-Mutated NSCLC and CNS Involvement: the Conundrum

  • pasty-toler
  • 0 Slides

This program will include a discussion of off-lab...

Raising the Bar in the Management of Advanced/Metastatic NSCLC

Raising the Bar in the Management of Advanced/Metastatic NSCLC

  • debby-jeon
  • 0 Slides

Dr Tan . Jiunn. Liang. Clinical Specialist (Resp...

OMICS International welcomes submissions that are original and technically so as to serve both th

OMICS International welcomes submissions that are original and technically so as to serve both th

  • lois-ondreau
  • 0 Slides

OMICS Journals are poised in excellence by publi...

Low TPS High TPS TPS = PD-L1 tumor proportion score Low TPS = 10%; high TPS = 60%

Low TPS High TPS TPS = PD-L1 tumor proportion score Low TPS = 10%; high TPS = 60%

  • olivia-moreira
  • 32 Slides

Low TPS High TPS TPS = PD-L1 tumor proportion sco...

ASCO 2019 NSCLC - PARP & Chemotherapy

ASCO 2019 NSCLC - PARP & Chemotherapy

  • mitsue-stanley
  • 12 Slides

ASCO 2019 NSCLC - PARP & Chemotherapy REF Stu...

The Role of Antiangiogenic Agents

The Role of Antiangiogenic Agents

  • luanne-stotts
  • 25 Slides

The Role of Antiangiogenic Agents in the Changin...

The Cancer genome atlas (TCGA) and the search for a CUP genetic/epigenetic signature

The Cancer genome atlas (TCGA) and the search for a CUP genetic/epigenetic signature

  • stefany-barnette
  • 15 Slides

The Cancer genome atlas (TCGA) and the search for...

Please note, these are the

Please note, these are the

  • disclaimercanon
  • 72 Slides

actual. . video-recorded proceedings from the . l...

Optimizing Nursing Management of Patients Receiving Novel Therapies for Advanced NSCLC

Optimizing Nursing Management of Patients Receiving Novel Therapies for Advanced NSCLC

  • southan
  • 67 Slides

Beth . Eaby. -Sandy, MSN, CRNP, OCN. ®. Nurse Pra...

Please note, these are the actual video-recorded

Please note, these are the actual video-recorded

  • chaptoe
  • 71 Slides

proceedings from the live CME event and may includ...

Lung cancer Treatment

Lung cancer Treatment

  • attentionallianz
  • 20 Slides

Consequences of the Lack of Patients of color &...

Module 13: Targeted Treatment

Module 13: Targeted Treatment

  • disclaimercanon
  • 49 Slides

of Lung Cancer . Wendi S Lee, MSN, RN, NP-C. Anne ...

Please note, these are the

Please note, these are the

  • vizettan
  • 84 Slides

actual. . video-recorded proceedings from the . l...

NA_00092076/ J1414, Protocol Version 4.8 Dated 13November2018

NA_00092076/ J1414, Protocol Version 4.8 Dated 13November2018

  • singh
  • 95 Slides

1 Study Title: Neoadjuvant Nivolumab, or Nivoluma...

Presented at the European Society for Medical Oncology 2019 Barcelona

Presented at the European Society for Medical Oncology 2019 Barcelona

  • lucy
  • 1 Slides

– 1 October, 2019 ● GSK 3377794 activate and i...

Copyright © 2024 DocSlides. All Rights Reserved